Cited by

• Hypercalcemia Associated With Severe Dysphagia in a Patient With Parathyroid Adenoma and Significant Cervical Spondylophytes.

  Čulina D, Peček M, Gregurić T, Aras I, Košec A, Stevanović S. Čulina D, et al. AACE Clin Case Rep. 2024 Feb 24;10(3):89-92. doi: 10.1016/j.aace.2024.02.004. eCollection 2024 May-Jun. AACE Clin Case Rep. 2024. PMID: 38799048 Free PMC article.
• Quality appraisal of clinical practice guidelines for the evaluation and management of primary hyperparathyroidism.

  Salmon MK, Fritz CG, Barrette LX, Romeo D, Suresh NV, Ng JJ, Balar E, Prasad A, Moreira A, Rajasekaran K. Salmon MK, et al. Endocrine. 2024 Aug;85(2):864-872. doi: 10.1007/s12020-024-03790-8. Epub 2024 Mar 29. Endocrine. 2024. PMID: 38551756 Free PMC article. Review.
• Hyperparathyroidism and Peripheral Arterial Disease.

  Antignani PL, Jezovnik MK, Blinc A, Mikhailidis DP, Anagnostis P, Schernthaner GH, Jensterle M, Studen KB, Sabovic M, Poredos P. Antignani PL, et al. Curr Vasc Pharmacol. 2024;22(2):88-94. doi: 10.2174/0115701611280905231227045826. Curr Vasc Pharmacol. 2024. PMID: 38284694 Review.
• Comparison of Neck Ultrasonography, Dual Phase ^99mTc-Sestamibi with early SPECT-CT & ¹⁸F-Fluorocholine PET-CT as First Line Imaging in Patients with Primary Hyperparathyroidism.

  Abhishek B, Wakankar R, Dharmashaktu Y, Damle NA, Kumar P, Bal C, Tripathi M, Kandasamy D, Khadgawat R, Agarwal S, Vuthaluru S, Chumber S. Abhishek B, et al. Indian J Nucl Med. 2023 Jul-Sep;38(3):208-217. doi: 10.4103/ijnm.ijnm_28_22. Epub 2023 Oct 10. Indian J Nucl Med. 2023. PMID: 38046978 Free PMC article.
• Differences in the Presentation and Outcome between Premenopausal and Postmenopausal Primary Hyperparathyroidism Indian Women: A Single-Center Experience.

  Maldar AN, Shah NF, Chauhan PH, Lala M, Kirtane MV, Chadha M. Maldar AN, et al. J Midlife Health. 2023 Apr-Jun;14(2):73-80. doi: 10.4103/jmh.jmh_142_22. Epub 2023 Sep 18. J Midlife Health. 2023. PMID: 38029031 Free PMC article.